SELECTIVE PRESSURE OF ANTISTAPHYLOCOCCAL CHEMOTHERAPEUTICS IN FAVOR OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS

被引:8
作者
BAUERNFEIND, A
EMMINGER, G
HORL, G
LORBEER, B
PRZYKLENK, B
WEISSLEINPFISTER, C
机构
关键词
D O I
10.1007/BF01647240
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:469 / 470
页数:2
相关论文
共 5 条
[1]   BACTERIOLOGICAL EFFECTS OF ANTIPSEUDOMONAS AERUGINOSA CHEMOTHERAPY IN CYSTIC-FIBROSIS [J].
BAUERNFEIND, A ;
EMMINGER, G ;
HORL, G ;
OTT, S ;
PRZYKLENK, B ;
WEISSLEINPFISTER, C .
INFECTION, 1987, 15 (05) :403-406
[2]   QUALITATIVE AND QUANTITATIVE MICROBIOLOGICAL ANALYSIS OF SPUTA OF 102 PATIENTS WITH CYSTIC-FIBROSIS [J].
BAUERNFEIND, A ;
BERTELE, RM ;
HARMS, K ;
HORL, G ;
JUNGWIRTH, R ;
PETERMULLER, C ;
PRZYKLENK, B ;
WEISSLEINPFISTER, C .
INFECTION, 1987, 15 (04) :270-277
[3]   BACTERIOLOGY OF SPUTUM IN CYSTIC-FIBROSIS - EVALUATION OF DITHIOTHREITOL AS A MUCOLYTIC AGENT [J].
HAMMERSCHLAG, MR ;
HARDING, L ;
MACONE, A ;
SMITH, AL ;
GOLDMANN, DA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (06) :552-557
[4]   PLACEBO-CONTROLLED TRIAL OF CEPHALEXIN THERAPY IN THE AMBULATORY MANAGEMENT OF PATIENTS WITH CYSTIC-FIBROSIS [J].
LOENINGBAUCKE, VA ;
MISCHLER, E ;
MYERS, MG .
JOURNAL OF PEDIATRICS, 1979, 95 (04) :630-637
[5]  
WONG K, 1984, MED MICROBIOL, V7, P113